Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1995-05-23
1998-08-11
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
435325, 4352351, 4351723, 4353201, 424 932, A61K 39295, C12N 510, C12N 701, C12N 1500
Patent
active
057924627
ABSTRACT:
The present invention provides a helper cell for expressing an infectious, replication defective, alphavirus particle in an alphavirus-permissive cell. The helper cell includes (a) a first helper RNA encoding (i) at least one alphavirus structural protein, and (ii) not encoding at least one alphavirus structural protein; and (b) a second helper RNA separate from the first helper RNA, the second helper RNA (i) not encoding the alphavirus structural protein encoded by the first helper RNA, and (ii) encoding the at least alphavirus one structural protein not encoded by the first helper RNA, such that all of the alphavirus structural proteins assemble together into alphavirus particles in the cell. Preferably, the helper cell also includes a replicon RNA encoding an alphavirus packaging sequence and an inserted heterogeneous RNA.
REFERENCES:
patent: 4650764 (1987-03-01), Temin et al.
patent: 5185440 (1993-02-01), Davis et al.
patent: 5217879 (1993-06-01), Huang et al.
Morgenstein et al. Advanced Mammalian Gene Transfer: High Titer Retroviral ectors with Multiple Drug Selection Markers and a Complementary Helper-Free Packaging Cell Line. Nuclear and Research 18:3587-3596, 1990.
Suomalainen et al. Spike Protein-Nucleocepsid Interactions Drive the Budding of Alphaviruses. J: Virol 66:4737-4747, 1992.
Davis et al Virology 212:102-110 1995.
N.L. Davis et al: Attenuating Mutations in the E2 Glycoprotein Gene of Venezuelan Equine Encephalitis Virus: Construction of Single and Multiple Mutants in a Full-Lenght cDNA Clone; Virology 183 20-31 (1991).
Davis et al: A Genetically Engineered Live Virus Vaccine for Venezuelan Equine Encephalitis; J. Cell Biochemistry Supplement O No. 17 Part D, issued 1993, Abstract N404.
R.J. Schoepp and R.E. Johnston; Directed Mutagenesis of a Sindbis Virus Pathogenesis Site; Virology 193, pp. 149-159 91993).
J.M. Polo and R.E. Johnston; Attenuating Mutations in Glycoproteins E1 and E2 of Sindbis Virus Produce a Highly Attenuated Strain When Combined in Vitro; Journal of Virology 64 No. 9; pp. 4438-4444 (1990).
P.J. Bredenbeek et al; Sindbis Virus Expression Vectors: Packaging of RNA Replicons by Using Defective Helper RNAs; Journal of Virology 67 No. 11; pp. 6439-6446 (1993).
Liljestrom et al.; A New Generation Of Animal Cell Expression Vectors Based On The Semliki Forest Virus Replicon; Bio/Technology, vol. 9, Dec. 1991, pp. 1356-1361.
Strauss et al.; The Alphaviruses: Gene Expression, Replication, and Evolution; Microbiological Reviews, Sep. 1994; pp. 491-562.
Russell, et al., Sindbis Virus Mutations Which Coordinately Affect Glycoprotein Processing, Penetration, And Virulence In Mice, Journal of Virology, vol. 63, No. 4, Apr. 1989, pp. 1619-1629.
Davis Nancy L.
Johnston Robert E.
Ludwig George
Parker Michael
Pushko Peter
Mosher Mary E.
The United States of America as represented by the Secretary of
University of North Carolina at Chapel Hill
LandOfFree
Alphavirus RNA replicon systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alphavirus RNA replicon systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alphavirus RNA replicon systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-386591